Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival

AIMS: The aim of this study was to examine the prevalence of amyloid transthyretin (ATTR) cardiac amyloidosis in patients 1–2 years after trans‐catheter aortic valve replacement (TAVR) and to assess their clinical and echocardiographic outcome and long‐term survival. METHODS AND RESULTS: We enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimoni, Sara, Zikri, Meital, Haberman, Dan, Livschitz, Shay, Tshori, Sagi, Fabricant, Yacov, Meledin, Valery, Gandelman, Gera, Goland, Sorel, George, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712785/
https://www.ncbi.nlm.nih.gov/pubmed/34704399
http://dx.doi.org/10.1002/ehf2.13667

Ejemplares similares

Ejemplares similares